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Essential fatty acid deficiency normalizes function and histology in rat
nephrotoxic nephritis. The central lipid abnormality in essential fatty
acid deficiency (EFAD) is the lack of availability of arachidonic acid.
To examine the role of total eicosanoid's biosyntheses in the pathology
and pathophysiology of glomerulonephritis, EFAD was induced in
weanling rats, which were then subjected to antiglomerular basement
membrane antibody (NTS)-induced injury in adulthood. Glomerular
dynamics (as assessed by micropuncture), quantitative histology, and
cicosanoid generation rates were measured at two hours and two weeks
post-NTS, and compared to those of standard diet-fed (STD) controls.
Two hours post-NTS, and despite the occurrence of proteinuria in both
EFAD and STD animals, glomerular dynamics were essentially normal
in EFAD rats, whereas STD animals had reduced values for glomerular
filtration rate (GFR) and renal plasma flow rate (RPF). At two weeks,
severe histologic changes were observed in STD animals including
mesangial and stalk hypercellularity, moderate sclerosis, and interstitial
nephritis, coupled with heavy proteinuria and reduced GFR and RPF.
In dramatic contrast, EFAD rats displayed totally normal glomerular
structures and functions. In parallel, glomerular generation rates of
prostaglandin E2 and thromboxane A2 were suppressed markedly in
EFAD rats. Thus, EFAD confers complete protection against the
histopathologic and functional sequelae of immune-initiated injury in
the glomerulus. The data suggest that the initial wave of complement-
induced neutrophil infiltration (with resultant proteinuria) is not suffi-
cient to perpetuate injury into the more destructive chronic phases. The
results provide strong impetus for the design of more specific interven-
tional therapies targeting the various enzymes and products of arachi-
donic acid metabolism in the attempts to control glomerular inflamma-
tion.
Clinical and experimental studies over the past three decades
have established a central role for biologically active ei-
cosanoids in the pathophysiology of glomerular immune injury.
The local synthesis and release of oxygenated metabolites of
arachidonic acid exerts profound effects on renal microvascular
tone, glomerular cell functions, glomerular filtration rate, and,
most significantly, histopathologic expression, during the evo-
lution of glomerulonephritis [1]. In addition to the known renal
actions of cyclooxygenase and lipoxygenase-derived products
of arachidonate metabolism (prostaglandins, thromboxanes,
leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids), re-
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cent studies have documented highly potent renal vasoconstric-
tor actions for a non-enzymatically generated class of prosta-
glandin F2-like compounds, synthesized by a free radical-
catalyzed mechanism [21, as well as cytochrome P450-derived
arachidonate epoxidation products [3, 4]. In its totality, there-
fore, enzymatic and non-enzymatic oxygenation of arachidonic
acid during glomerular inflammation appears to play a central
role in the mediation of glomerular dysfunction and ultimate
destruction. A formal evaluation and definition of this proposed
role for total arachidonate metabolism in experimental glomer-
ulonephritis, however, remained lacking.
In the present study, we employed essential fatty acid defi-
cient (EFAD) animals to dissect the impact of total arachido-
nate depletion on the course of anti-glomerular basement mem-
brane (anti-GBM) antibody [nephrotoxic serum (NTS)}-induced
glomerulonephritis in the rat. It is well established that, when
animals are rendered deficient in essential fatty acids, the
cellular levels of arachidonic acid decrease markedly [5, 6].
EFAD offers the added advantage, in addition to depleting a
precursor for eicosanoids biosyntheses, of inhibiting macro-
phage elicitation without the use of systemic immunosuppres-
sive manipulations [7]. The latter phenomenon is itself likely
due to the abrogation of the local generation of an arachidonate-
related macrophage chemoattractant lipid, the structural iden-
tification of which is currently underway [8]. NTS glomerulo-
nephritis was therefore induced in standard diet-fed (STD) and
EFAD rats, and glomerular functional alterations were assessed
by glomerular micropuncture, in parallel with histopathologic
examinations and measurements of glomerular eicosanoids
productions during both the acute (heterologous), as well as the
chronic (autologous) phases of injury.
Methods
Preparation of NTS
NTS was produced by repeated immunization with basement
membrane-rich sediment of rat cortex, as previously described
[9]. The dosage of NTS was determined in a preliminary study
by examining the dose required to induce heavy proteinuria
(200 to 300 mg protein/day) in the first 48 hours after intrave-
nous injection. All rats received a standardized dose of 0.05 ml.
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Induction of EFAD
Weanling male Munich-Wistar rats were obtained and fed
either a standard lab diet or a fat-free diet (Purina Test Diets,
Richmond, Indiana, USA) for three months. The fatty acid
analysis of these diets has been published previously 110]. A
previous study [5] indicated that this protocol results in liver
and glomeruli being deficient in fatty acids as assessed by
20:3(n-9) to arachidonate ratio of >0.4, which is the biochemi-
cal criterion for EFAD [11]. Individual experiment was per-
formed with age-matched controls that had been on a standard
diet for an equivalent period to the EFAD animals.
Induction of NTS nephriiis andexperimental protocol
Acute study (heterologous phase)
All experiments were performed on anesthetized male
Munich-Wistar rats weighing 150 to 180 g which were prepared
for micropuncture according to protocols described below. In
all experiments, micropuncture measurements were started 120
to 150 minutes after the administration of either non-immunized
serum or NTS. In this study, rats were divided into four
experimental groups as follows.
Group IA (N = 6).This group of animals were STD rats to
which 0.05 ml of non-immunized serum, the vehicle for NTS,
was administered intravenously.
Group hA (N = 5).This group of animals were STD rats, but
received 0.05 ml of NTS.
Group lilA (N = 5).These animals were EFAD rats which
received 0.05 ml of non-immunized serum as in Group IA.
Group IVA (N = 5).These animals were EFAD rats which
received 0.05 ml of NTS as in Group lilA.
Chronic study (autologous phase)
Rats weighing 150 to 180 g were maintained in metabolic
cages on either a standard or a fat-free rat diet and allowed free
access to water. After 24-hour urine collection for the measure-
ment of baseline protein excretion, NTS or non-immunized
serum was administered intravenously and 24-hour urine pro-
tein excretion was monitored daily until 14 days after NTS
injection, when micropuncture and morphologic studies were
performed.
In this study, rats were divided into four experimental groups
as follows.
Group IC (N = 7).This group of animals were STD rats to
which 0.05 ml of non-immunized serum was administered
intravenously.
Group JIG(N = 6).This group of animals were STD rats, but
received 0.05 ml of NTS.
Group JuG (N 6).These animals were EFAD rats which
received 0.05 ml of non-immunized serum as in Group IC.
Group IVC (N 6),These animals were EFAD rats which
received 0.05 ml of NTS as in Group IIIC.
Micropuncture study
Rats were prepared for micropuncture according to protocols
described previously [91. In brief, following mactin anesthesia
(Andrew Lockwood & Associates, Sturtevant, Wisconsin), the
left femoral artery catheter was used to monitor mean system
arterial pressure (AP) by means of a pressure transducer
(P23Db, Statham Instruments, Oxnard, California, USA) con-
nected to a direct writing recorder (Gould Instruments Inc.,
Cleveland, Ohio, USA) and for sampling of blood. Jugular veins
were catheterized for infusion of plasma and a solution of
3H-inulin (300 pCi/experimental period in 0.9% NaC1) and
para-aminohippurate (PAH) (0.32 mg/mm) at 1.2 mllhr. The left
kidney was exposed on a Lucite holder. The kidney surface was
illuminated with a fiberoptic light source and bathed with
isotonic NaC1, Homologous rat plasma was administered intra-
venously to replace surgically-induced plasma losses, thus
maintaining euvolemia [12], at a rate of 10 mb/kg/hr for 45
minutes followed by a reduction in infusion rate to 1.5 mb/kg/hr
for the remainder of the experiment. The plasma from EFAD
rats was used for the experiments in EFAD rats. In all experi-
ments micropuncture measurements were started 45 minutes
after the onset of plasma infusion and carried out as follows:
two-minute samples of fluid were collected from surface prox-
imal convolutions for determination of flow rate and inulin
concentration. Concomitantly, femoral arterial blood was ob-
tained in each period for determination of systemic arterial
hematocrit (Hct) and plasma protein and inulin concentrations.
In addition, two or three samples of urine from the experimental
kidney were collected for the determination of flow rate, inulin
and PAH concentrations, and for the calculation of whole
kidney glomerular filtration rate (GFR) and plasma flow rate
(RPF). Three samples of blood were obtained from surface
efferent arterioles (star vessels) for determination of efferent
arteriolar protein concentration. Time-averaged hydraulic pres-
sures were measured in surface glomerular capillaries (0),
proximal tubules (PT), and surface efferent arterioles (PE) using
a continuous recording, servo-null micropipette transducer
system (Model 5, Instrumentation for Physiology and Medicine,
San Diego, California, USA) and micropipettes with outer tip
diameters of 2 to 3 m and containing 2.0 M NaG!. Colloid
osmotic pressures of plasma entering and leaving glomerular
capillaries, single nephron glomerular filtration rate (SNGFR),
single nephron filtration fraction (SNFF), glomerular capillary
ultrafiltration coefficient (Kf), resistance of single afferent (RA)
and efferent (RE) arterioles, and initial glomerular capillary
plasma flow (SNPF), were determined using equations de-
scribed in detail elsewhere [13]. The concentrations of inulin in
tubule fluid, plasma and urine were determined by measuring
the radioactivity of 3H-inulin in a scintillation counter (Beck-
man Instruments, Fullerton, California, USA). The concentra-
tion of PAH in urine and plasma was determined according to
the method of Smith, Finkelstein and Aliminosa [14]. Protein
concentration in efferent arteriolar and femoral arterial blood
plasmas were determined using a fluorometric method devel-
oped by Viets et al [15]. In Group IC-IVC, glomeruli were
isolated right after the experiment, for in vitro experiments and
morphologic studies described below.
Glomerular isolation, eicosanoid generation measurements
In the chronic study, following micropuncture studies, re-
moval of kidneys, a small section was dissected for morpho-
logic study. Following separation of cortices from medullae,
glomeruli were isolated by a modification of the differential
sieving technique [91, aimed at optimizing glomerular viability.
In brief, the removed kidneys were immediately placed in
Krebs buffer consisting of 105 mr'i NaCl, 24 mM NaHCO3, 5 mM
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Table 1. Summary of values for systemic and single nephron parameters
Group
Hct
vol %
MAP
mm Hg
GFR RPF
mi/mm FF
SNGFR
ni/mm
SNPF
SNFF
P
mm
Hg
RA RE
1010 dyn sec cm5
Kf
nl/(sec.
mm Hg)
IA
HA
LIlA
IVA
43
I
47b
2
45
1
44
I
112
2
I2l
3
109
4
110
2
0.96 3.86
0.04 0.18
030b 104b
0.08 0.42
1.03 4.10
0.09 0.10
0.87 3.96
0.07 0.14
0.26
0.01
•3a
0.01
0.25
0.01
0.24
0.01
38.8
3.4
195b
0.8
39.4
1.9
36.8
1.8
142
6
62b
3
155
6
160
10
0.28
0.01
0.35°
0.03
0.26
0.01
0.24
0.01
35
1
4o
I
38
I
36
1
2.19 1.48
0.19 0.09
418b 332b
0.35 0.39
1.80 1.31
0.22 0.13
1.83 1.13
0.12 0.06
0.055
0.006
0019b
0.002
0.049
0.007
0.037
0.004
a P < 0.05, b P < 0.01 vs. Group LA
KCI, 2 mri Na2HPO4, 1 mi MgSo4, 1.5 mivi CaCI2, 5 mM
glucose, 10 mM HEPES, and 0.2% BSA at pH 7.4, which was
pre-bubbled with 95% 02/5% CO2 for 30 minutes. The cortical
tissue was then minced at 4°C and transferred to another
solution containing 0.3 mg/mI collagenase Sigma, Type I, (Sig-
ma Chemical Co., St. Louis, Missouri, USA) in Krebs buffer,
and bubbled in this solution with 95% 02/5% CO2 for 45 minutes
at 37°C. Differential sieving was then carried out by passing
cortical tissue sequentially through 150 and 75 micron sieves,
with warming and gentle centrifugation. The glomerular prepa-
ration that was obtained was >95% pure. This modification of
the conventional sieving technique does indeed assure greater
viability of glomerular cells [5]. The isolated glomeruli were
then incubated in Krebs buffer maintained at 37°C and 5% CO2
for 30 minutes for measurement of prostaglandin E2 (PGE2) and
thromboxane B2 (TxB2), the stable metabolite of TxA2. The
preparation was then centrifuged and divided into the superna-
tant and the glomerular pellet. The supernatant was frozen at
—70°C for eicosanoids measurements at a later time, and the
glomeruli were used for protein assay. The protein content of
the pelleted glomeruli was assayed by a colorimetric method
(Bio-Rad protein assay). The amounts of PGE2 and TxB2
generated by these glomeruli over the time period of incubation
were determined by radioimmunoassay (Amersham) [9].
Histological analysis
Kidney sections from each animal in Groups IC-IVC were
fixed in 10% buffered formalin. Six-micrometer paraffin sections
at least 100 tm apart were then evaluated by several criteria.
The number of glomeruli displaying focal segmental sclerosis
was expressed as a percentage of total glomeruli. This lesion
was distinctive for its hypercellularity and asymmetrical in-
volvement of the affected glomerulus (Fig. 2B). The sclerotic
area consisted of mesangial expansion, obliteration of the
capillary bed, and increased numbers of cells with the nuclear
morphology of macrophages. Many of the glomeruli in the
nephritic groups manifested hypercellularity in the juxtaglomer-
ular (JG) region, between the mesangial stalk and macula densa.
Those glomeruli in which this region could be clearly visualized
and which manifested at least a doubling of the nuclear counts
normally observed in this region were scored as (+) for JG
hypercellularity and expressed as a % (N = 25). Intraglomerular
cellularity was assessed by enumeration of mononuclear cells
within glomeruli whose size was arbitrarily chosen to be 125 to
150 pm in both the horizontal and vertical axes. This was done
to provide a standardized glomerular size for reference and to
minimize the statistical variability arising from enumeration of
glomeruli heterogenously sized due to the level at which they
were sectioned. We observed that most of the hypercellularity
observed in nephritic glomeruli was attributable to increases in
mesangial cellularity that was readily apparent even in glomer-
uli not exhibiting sclerosis. The increased mesangial cellularity
was typically asymmetrically distributed. In order to quantitate
this, we counted the nuclei in the most cellular mesangial region
of the peripheral loops of glomeruli not exhibiting segmental
sclerosis. The mesangial nuclei were counted as the number of
nuclei per 62.5 nm2 of mesangium. The enumeration was
restricted to peripheral capillary loops in order to avoid the
mesangial stalk region, and is defined as maximum mesangial
cell accumulation. Finally, PMN counts were conducted assay-
ing glomeruli with the same dimensions noted above. Results
were expressed as mean PMN counts per glomeruli. Interstitial
nephritis was evaluated by counting the number of extratubular
interstitial cells per 25 .tm2 high power field in 10 randomly
selected fields lacking a glomerulus. Results are expressed as
the arithmetic mean SEM.
Statistical
Intergroup comparisons were performed by one-way analysis
of variance, followed by Neumann-Keul multiple comparison.
Differences were considered significant at a P value 0.05. All
values are reported as mean SEM.
Results
Acute study
Morphologic and biochemical studies were not performed in
the acute study, since these have been published previously [7].
Micropuncture studies (Table 1).The pattern of systemic,
whole kidney, and glomerular microcirculatory hemodynamic
parameters observed in STD rats two hours following adminis-
tration of non-immunized serum (Group IA) was similar to that
previously established for baseline control values in the euvo-
lemic Munich-Wistar rat [9] and is presented in the top panels of
Table 1. Additionally, no significant difference was noted in any
parameters between EFAD non-nephritic animals (Group lilA)
and STD non-nephritic rats (Group LA). Administration of NTS
to STD rats (Group hA) was associated with an elevated value
of AP and Hct (AP: 121 3 vs. 112 2 mm Hg in Group IA;
P < 0.005 Hct: 47.0 2.0 vs. 43.0 1.0 vol% in Group 1A; P
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< 0.005), a phenomenon not observed in EFAD nephritic
animals in Group IVA (AP: 110 2 vs. 109 4 mm Hg in
Group lilA, NS. Hct: 43.6 0.4 vs. 45.0 1.0 in Group lilA,
NS). Further, this induction of NTS nephritis in STD rats
(Group hA) was associated with reductions in GFR and RPF,
and an elevation in filtration fraction (FF) as compared to STD
non-nephritic rats in Group IA. The values were: GFR, 0.30
0.08 vs. 0.96 0.04 mI/mm, P < 0.005; RPF, 1.04 0.42 vs.
3.86 0.18 mI/mm, P < 0.005; FF, 0.30 0.01 vs. 0.26 0.02;
P < 0.05, respectively. In contrast, administration of NTS to
EFAD rats in Group IVA was associated with complete pres-
ervation of GFR, RPF and FF as compared to EFAD non-
nephritic rats in Group lilA (GFR: 0.87 0.07 vs. 1.03 0.09
ml/min, NS; RPF: 3.96 0.14 vs. 4.10 0.10 mllmin, NS; FF:
0.24 0.01 vs. 0.25 0.01, NS, respectively).
In parallel with these changes in whole kidney GFR, RPF and
FF, single nephron measurements revealed a fall in SNGFR,
SNPF and an elevation in SNFF in STD nephritic rats in Group
hA as compared to STD non-nephritic rats in Group IA
(SNGFR: 19.5 0.8 vs. 38.8 3.4 nI/mm, P < 0.005; SNPF: 62
3 vs. 142 6 nI/mm, P < 0.005; SNFF: 0.35 0.03 vs. 0.28
0.01, P <0.005, respectively). The administration of NTS in
EFAD rats in Group IVA was associated with preservation of
SNGFR, SNPF and SNFF (SNGFR; 36.8 1.8 vs. 39.4 1.9
ni/mm, NS; SNPF: 160 10 vs. 155 6 nllmin, NS; SNFF:
0.24 0.01 vs. 0.26 0,01, NS, respectively). Measurements
in P0, T' and PE revealed that induction of acute NTS-
induced glomerular injury in STD animals (Group hA) was
associated with an elevation in mean transcapillary hydraulic
pressure difference, iP (40 1 vs. 35.1 mm Hg in Group IA, P
< 0.005), a phenomenon not observed in Group IVA EFAD
nephritic rats (36 1 vs. 37 1 mm Hg in Group lilA, NS).
Mean values of superficial cortical pressure measurements in
these groups of animals are summarized in Table 1. Calculation
of R and RE revealed that STD nephritic rats in Group hA
were characterized by significant increases in both of these
parameters as compared to STD non-nephritic rats in Group IA
(RA: 4.18 0.35 vs. 2.19 0,19 1010 dyn sec cm5, P <
0.005; RE: 3.32 0.39 vs. 1.48 0.09 10'° dyn sec cm5, P
<0.005). Hence, a proportionally greater increase was attained
in R as compared to RA. These NTS-induced changes in RA
and RE were not observed in EFAD rats in Group IVA (RA:
1.83 0.12 vs. 1.80 0.22 i'° dyn sec cm in Group lilA,
NS; RE: 1.13 0.06 vs. 1.31 0.13 l0'° dyn sec cm5 in
Group lilA, NS). The presence of filtration pressure disequi-
librium allowed for the calculation of unique values for Kf in all
the experimental animals. In Group hA, a dramatic reduction in
the mean value for this parameter was observed [0.019 0.002
vs. 0.055 0.006 nl/(sec mm Hg) in Group IA, P < 0.005].
This marked fall in Kf was nearly absent in EFAD nephritic rats
in Group IVA when compared to EFAD non-nephritic animals
(Group lilA) [0.037 0.004 vs. 0.049 0.007 nlI(sec mm Hg),
respectively, NS].
Urinaty protein excretion
Total urinary protein excretion (Upr) two hours following
administration of NTS in STD rats in Group hA averaged 574
93 xgImin, a value significantly higher than 10 2 j.rg/min in
STD non-nephritic animals in Group IA (P < 0.005; Fig. 1). In
contrast to hemodynamic parameters, this increase in Upr was
STD STD + NTS EFAD EFAD + NTS
Fig. 1. Urinary protein excretion (Un,) in Groups JA to IVA. Abbrevi-
ations are: STD, standard-diet fed rats (Group 1A); STD + NTS,
standard-diet fed rats receiving NTS (Group HA); EFAD, essential
fatty acid deficient rats (Group lilA); EFAD + NTS, essential fatty acid
deficient rats receiving NTS (Group IVA). * P < 0.005 vs. Group IA,
t P < 0.05 vs. Group hA, P < 0.001 vs. Group lilA.
only partially attenuated in EFAD nephritic rats in Group IVA,
though the value was significantly lower than that of Group HA
[IVA: 336 36 pg/min, P < 0.05 vs. Group IIA, and P <0.005
vs. EFAD non-nephritic rats in Group lilA (7.2 2 p.g/min)].
Chronic study
Morphologic examination.Com pared to the normal glomeruli
of STD rats receiving non-immunized serum (Fig. 2A), STD
rats receiving NTS manifested a mesangioproliferative form of
glomerulonephritis in the autologous phase of the disease (Fig.
2B). Diffuse mesangial hypercellularity and focal segmental
sclerosis were present. The sclerotic regions were associated
with mesangial expansion, obliteration of the capillary bed
locally, and increased cellularity. Many of the cells demon-
strated a nuclear morphology characteristic of macrophages.
The induction of nephritis was associated with an increase in
the percent of glomeruli with focal sclerosis from 1.5 1.5% for
STD non-nephritic animals in Group IC to 26.0 2.3% for STD
nephritic rats in Group IIC (P < 0.01). In marked contrast,
EFAD nephritic animals in Group IVC (Fig. 2C) failed to
develop the lesion (0.8 0.5 vs. 0.7 0.7% for EFAD
non-nephritic animals in Group IIIC, NS).
EFAD rats receiving NTS (Group IVC) were also protected
against the glomerular hypercellularity exhibited by STD ne-
phritic rats in Group IIC (131.4 3.6 vs. 83.9 3.5 for EFAD
nephritic animals in Group IVC, P < 0.01). Indeed, their
glomerular cell counts were not statistically different from
non-nephritic rats on either a standard or EFAD diet. In parallel
to these findings, EFAD nephritic glomeruli experienced no
significant mesangial cell increase when compared to STD
nephritic rats (3.3 0.4 peak mesangial cell accumulation
compared to 10.9 0.4 for STD nephritic rats, P <0.01), and
did not statistically differ from non-nephritic animals from
either dietary group.
Interestingly, STD nephritic animals in Group hIC demon-
strated a marked increase in the cellularity of the JG region
(36.0 10.6 vs. 8.0 4.0% for STD non-nephritic rats in Group
IC, P <0.05). EFAD animals exhibited a decrease in JG region
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Fig. 2. Representative light micrograph of a
glomerulus of a normal rat (A), a standard-
diet fed rat which received NTS (B) and a
EFAD rat which received NTS (C).
cell accumulation both as non-nephritic (2.7 1.3%, Group STD nephritic rats displayed only a mild PMN infiltrate (1.5
IIIC) and after receiving NTS (3.2 1.5%, Group IVC). 0.1 vs. 0.2 0.1 per glomerulus for STD non-nephritic rats in
As expected for the autologous phase of glomerulonephritis, Group IC, P < 0.01). EFAD nephritic animals showed no
—
Is
 
tre
e 
a
 
a
 
I 4 
1250 Takahashi et a!: EFAD and glomeru!onephritis
Table 2. Summary of morphologic quantification
Group IC IIC IIIC IYC
% Glomeruli displaying focal segmental sclerosis 1.5 1.5 26.0 23b 0.7 0.7 0.8 0.5
% Glomeruli displaying JG hypercellularity 8.0 4.0 36.0 l0.6a
Glomerular nuclear counts 83.6 2.1 131.4 3.6k'
2.7 1.3
83.4 0.7
3.2 1.5
83.9 3.5
Peak concentration of mesangial cell accumulation 3.4 0.1 10.9 04b 2.3 0.2 3.3 0.4
Number of PMN per glomerulus 0.2 0.1 1.5 0.1k'
Interstitial infiltrate (Interstitial cells 25 2 field) 8.5 0.2 20.5 2.Oa
0.3 0.1
9.8 0.1
0,3 0.1
10.7 1.1
Explanations for each parameter are in the text.
P < 0.05, b P < 0.01 vs. Group IC
Table 3. Summary of values for systemic and single nephron parameters
GFR RPF SNGFR SNPF
MAP mm R,., R K1ni (sec.
Group Hct mm Hg mi/mm FF ni/mm SNFF Hg 1010 dyn . sec cm5 mm Hg)
IC 47 107 1.17 4.24 0.28 50.6 179 0.28 34.5 1.44 1.10 0.064
±1 ±5 ±0.08 ±0.27 ±0.01 ±2.6 ±7 ±0,01 ±1.3 ±0.10 ±0.04 ±0.008
IIC 44 102 088b 57a 019b 331b l98 017b 418b I.20 1.25 0026b
±1 ±2 ±0.04 ±0.20 ±0.01 ±1.4 ±8 ±0.01 ±0.7 ±0.11 ±0.07 ±0.002
HIC 46 110 1.10 3.92 0.27 46.0 166 0.28 38.0 1,43 1.15 0.050
±1 ±4 ±0,17 ±0.33 ±0.03 ±1.9 ±12 ±0.01 ±0.7 ±0.13 ±0.12 ±0.007
IVC 45 104 1.03 3.98 0.24 44.3 170 0.26 38.0 1.40 1.16 0.047
±1 ±4 ±0.09 ±0.02 ±0.01 ±5.0 ±17 ±0.01 ±1.4 ±0.11 ±0.17 ±0.008
P < 0.05, ' P < 0.01 vs. Group IC
increase in PMN infiltrate compared to EFAD non-nephritic
animals.
Finally, we noted that this form of glomerulonephritis was
associated with a non-necrotizing interstitial infiltrate (20,5 ±
2.0 interstitial cells per 25 m' field compared to 8.5 ± 0.2 for
STD non-nephritic rats in Group IA, P < 0.05). Again, EFAD
nephritic rats were completely protected.
These results are summarized in Table 2.
Micropuncture studies
As in acute study, the pattern of systemic, whole kidney, and
glomerular microcirculatory hemodynamic parameters ob-
served 14 days following the administration of non-immunized
serum in STD (Group IC) and EFAD animals (Group IIIC) was
similar to that previously established for baseline control values
in the euvolemic Munich-Wistar rat [9] and is presented in
Table 3. The induction of the autologous phase of NTS-
nephritis was without effect on AP. No significant differences in
AP and Hct were observed among the four Groups. GFR was
mildly but significantly depressed in Group IIC animals as
compared to Group IC controls, the values were 0.88 ± 0.04
versus 1.17 ± 0.08 mI/mm, respectively, P < 0.05. However,
the induction of nephritis in EFAD rats in Group IYC was not
associated with a significant reduction in GFR as compared to
Group IIIC rats (1.03 ± 0.09 vs. 1.10 ± 0.17 mllmin, respec-
tively, NS). RPF was significantly greater in Group IIC animals
than that of Group IC controls (5.07 ± 0.20 vs. 4.24 ± 0.27
mI/mm, respectively, P < 0.05). However, RPF in EFAD
nephritic rats in Group IVC was not significantly different from
those in EFAD non-nephritic animals in Group IIIC. Thus FF in
Group IIC animals was lowered to 0.19 ± 0.01, values signifi-
cantly lower than those of Group IC (0.28 ± 0.01, P < 0.05 vs.
Group IIC), whereas no significant difference in FF was ob-
served between Group IIIC and IVC.
In parallel with these changes in whole kidney GFR, RPF and
FF, single nephron measurements revealed a fall in SNGFR and
SNFF, an increase in SNPF in STD nephritic rats in Group IIC
as compared to STD non-nephritic rats in Group IC (SNGFR:
33.1 ± 1.4 vs. 52.6 ± 2.6 nl/min, respectively, P < 0.01; SNFF:
0.19 ± 0.01 vs. 0.27 ± 0.01, respectively, P < 0.05; SNPF: 196
± 8 vs. 179 ± 7 nI/mm, respectively, P < 0.05). Similarly, the
induction of autologous nephritis in EFAD rats in Group IVC
was associated with a preservation of SNGFR, SNPF and
SNFF as compared to EFAD non-nephritic rats in Group IIIC
(SNGFR: 44.3 ± 5.0 vs. 46.0 ± 1.9 nI/mm, respectively, NS;
SNPF: 170 ± 17 vs. 166 ± 12 nllmin, respectively, NS; SNFF:
0.25 ± 0.01 vs. 0.26 ± 0.01, respectively, NS). The mean value
of isP in autologous NTS-nephritis in STD rats in Group IIC
was significantly higher than that of STD non-nephritic rats
Group IC (41.8 ± 0.7 vs. 34.5 ± 1.3 mm Hg, respectively, P <
0.05). However, again, no significant difference in AP was noted
between EFAD nephritic (Group IVC, 38.0 ± 1.4 mm Hg) and
non-nephritic rats (Group IIIC, 38.0 ± 0.7 mm Hg). Mean
values of superficial cortical pressure measurements in the four
Groups of animals are summarized in Table 3. RA in STD
nephritic rats in Group IIC was significantly reduced as com-
pared to STD non-nephritic rats in Group IC (1.17 ± 0.11 vs.
1.44 ± 0.10 lOb dyn' sec cm5, P < 0.05), while RE was
elevated significantly (1.25 ± 0.07 vs. 1.10 ± 0.04 10'°
dyn sec cm5, P < 0.01). However, both resistances in
EFAD nephritic rats in Group IVC were unchanged as com-
pared to EFAD non-nephritic rats in Group IIIC (RA: 1.40 ±
0.11 vs. 1.43 ± 0.13 lOb dyn sec 'cm, respectively, NS;
RE: 1.16 ± 0.17 vs. 1.15 ± 0.12 lOb dyn sec 'cm5, respec-
tively, NS). K1 of Group IIC showed a dramatic reduction in the
mean value for this parameter (0.026 ± 0.002 vs. 0.064 ± 0.008
nlI(sec mm Hg) in Group IC, P <0.01). However, this marked
fall in K1 was completely prevented in EFAD nephritic rats in
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Fig. 3. Mean values for glomerular generation rates of TxB2 (solid
bars) and PG2 (hatched bars) in Groups IC to IVC. Abbreviations are:
STD, standard-diet fed rats (Group IC); STD + NTS, standard-diet fed
rats receiving NTS (Group IIC); EFAD, essential fatty acid deficient
rats (Group IIIC); EFAD + NTS, essential fatty acid deficient rats
receiving NTS (Group IVC). * P < 0.005 vs. Group IC, t P < 0.05 vs.
Group IIIC, P < 0.001 vs. Group tIC.
Group IVC as compared to EFAD non-nephritic animals in
Group IIIC (0.047 0.008 vs. 0.050 0.007 nl/(sec mm Hg),
respectively, NS).
Glomerular eicosanoids production
The glomeruli freshly isolated from STD nephritic rats in
Group IIC showed increased productions of PGE2 and TxB2
expressed as pg/mg glomerular protein by as much as six- and
eight-fold, respectively (Fig. 3). PGE2 and TxB2 production of
glomeruli from EFAD non-nephritic rats in Group IIIC was
suppressed by 72 and 56%, respectively, as compared to those
from STD non-nephritic rats in Group IC. NTS-induced in-
creased production of these eicosanoids was also suppressed
markedly in the EFAD nephritic rats in Group IVC (Fig. 3).
Urinary protein excretion (Upr)
Upr of STD nephritic rats in Group IIC expressed as mg/day
increased from baseline at 5.8 1.4 to 327.8 17.6 (P < 0.001)
in two to three days following NTS injection and reduced
rapidly until seven to nine days. The Un,. remained constant and
was 44.2 11.5 at 14 days, a value which was significantly
higher than that observed at 14 days in Group IC rats (9.7 0.6,
P < 0.01). In contrast, Upr in EFAD nephritic animals in Group
IVC fell to normal level by 10 days and was 10.1 1.5 at 14
days (NS, vs. 8.0 1.0 in EFAD non-nephritic animals in
Group IIIC animals; Fig. 4).
Discussion
Dietary deprivation of essential fatty acids exerted profound
effects on every aspect of glomerular immune injury in this
model of glomerulonephritis in the rat. These included complete
normalization of glomerular filtration function and histology, as
well as marked improvement in glomerular permselectivity.
The data on inhibition of prostaglandin and thromboxane syn-
theses presented in Figure 3, coupled with the previously
demonstrated marked suppression of the early increase in LTB4
Time, day post-NTS
Fig. 4. Time course ofurinary protein excretion (Un,) in Groups IC to
IVC. Symbols are: open square, standard-diet fed rats (Group IC);
closed square, standard-diet fed rats receiving NTS (Group LIC); open
circle, essential fatty acid deficient rats (Group IIIC); closed circle,
essential fatty acid deficient rats receiving NTS (Group IVC) *
0.001 vs. basal values (Day 0), t P < 0.01 vs. correspondent values in
Group IC.
synthesis in EFAD nephritic glomeruli under basal as well as
angiotensin lI-stimulated conditions [5] attest to the efficacy of
this dietary manipulation in inhibiting eicosanoids generation
under normal and inflamed conditions.
Normalization of glomerular hemodynamics
The pattern of glomerular dynamics observed in our STD
animals during both the acute and the chronic phases of NTS
injury is identical to that published previously by us and others
[11. Studies performed during both the heterologous and autol-
ogous phases demonstrate that the principal factor accounting
for the fall in filtration rates in this model of injury is a marked
reduction in K [1, 9, 161. While K is low throughout both
phases of the disease process, renal vascular resistance (RVR)
is initially elevated during the heterologous phase [16], but
eventually falls as the lesion transforms into the autologous
phase and, at 10 to 14 days post-initiation of injury, RVR may
be equal to or even less than that observed in control animals
[9]. Of interest, micropuncture measurements reveal that in the
heterologous phase, both RA and RE are elevated, but RE is
proportionately greater so that P0 and P are higher than
normal [9, 16]. In the late phase, however, RVR is low due to a
dramatic reduction in RA with relative maintenance of RE,
resulting in persistently elevated P and P [9, 16]. Evidence
from a number of laboratories suggests strongly that the evolv-
ing changes in arteriolar tone during the course of this inflam-
matory lesion are mediated principally by locally released
cyclooxygenase and lipoxygenase arachidonate metabolites of
arachidonic acid [9, 16—191.
The studies of Lianos, Andres and Dunn [171 and of Stork
and Dunn [18] have established an important role for TxA2
release in mediating the increased RVR observed during the
early phase of this disease. Their studies also suggest that by
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day 1, the increasing rate of POE2 generation may account for
the progressive dilatation of renal arterioles leading to progres-
sive increases in renal blood flow (RBF) at this and later stages
[17, 181. In these studies, TxA2 antagonism appeared to ame-
liorate the falls in RBF and GFR two hours post-NTS, but not
at one day [17, 18]. Antagonism of the LTD4 receptor, on the
other hand, normalizes K1 without affecting vascular resis-
tances during acute NTS nephritis, suggesting that lipoxygen-
ase products play a significant role with regard to the falls in K1
and GFR during this early phase [16]. In the present study,
deprivation of arachidonic acid through EFAD prevents the
hiosyntheses of both cyclooxygenase and lipoxygenase prod-
ucts of arachidonic acid, thereby totally normalizing vascular
resistances as well as K1.
As noted above, the autologous phase of this form of exper-
imental glomerulonephritis is characterized by renal vasodila-
tion, and not vasoconstriction, though the GFR remains de-
pressed. Of interest, human glomerulonephritis is also often
associated with moderate to severe reductions in GFR despite
relative preservation, or even augmentation, of RPF [20, 21].
Current evidence favors a predominant role for cyclooxygenase
products in mediating both the renal vasodilation as well as the
reduction in K1 [9], and hence GFR, which characterize this
phase. Again, the total absence of significant alterations in
glomerular dynamics in EFAD nephritic animals provides con-
clusive evidence for the central role of lipid-derived mediators
in the pathogenesis of these abnormalities. Of interest, selective
inhibition of cyclooxygenase in this experimental model results
in marked increases in RA to values far exceeding those of
normal animals [9]. This had suggested the presence of potent
non-cyclooxygenase dependent vasoconstrictors, acting pri-
marily at preglomerular resistance sites, at this stage of injury,
whose actions are masked by the marked stimulation of vaso-
dilator cyclooxygenase derivatives (likely POE2) [9], but which
become evident during cyelooxygenase inhibition. The predom-
inant afferent action of these putative mediators argued against
the involvement of angiotensin II or peptidoleukotrienes, which
exert their constrictor actions predominantly on postglomerular
arterioles [22, 231. Since EFAD abolishes all changes in glomer-
ular vascular resistance in these animals, such vasoconstrictive
influences could also be derived from arachidonic acid, and
might well represent shunting of this precursor into non-
enzymatic formation of the recently described PGF2-like com-
pounds, which are potent renal vasoconstrictors [2].
Normalization of glomerular histology
NTS nephritis is characterized by initial influx of neutrophils
in the first two to three hours which is followed by a comple-
ment-independent infiltration of maerophages over the subse-
quent 72 hours [7]. The latter is maintained for at least 14 days
after the injection of NTS [9]. The influence of EFAD on the
histologic changes of the heterologous phase of injury have
been published previously [7], and were not addressed in the
present study. In that study, EFAD appears to have little effect
on the initial infiltration by neutrophils, a process which is
largely complement-dependent [7]. Here, we focused our his-
tologic studies on the more relevant chronic phase of injury. At
two weeks post-NTS, the glomerular lesions of STD nephritic
rats included focal segmental hypercellular sclerosis, mesangial
hypercellularity and intense interstitial infiltrate, which repre-
sent a more intense form of injury than that reported in our
previous study [9]. This may be attributed to the more potent
NTS batch used in the current study, as evidenced by the
greater degree of initial proteinuria and more profound reduc-
tions of SNGFR and K1. These changes were also associated
with greater increases in glomerular production rates of TxB2
and POE2 which play important roles in mediating glomerular
functional alterations in autologous NTS nephritis [9]. As the
summary of quantitative histology presented in Table 2 indi-
cates, EFAD was associated with a dramatic absence of his-
tologic abnormalities two weeks after the induction of injury.
This occurred despite clear presence of stigmata of initial injury
(that is, antibody binding, early neutrophil infiltration, and early
proteinuria) at two hours post-NTS when this disease model is
induced in EFAD rats [5] (Fig. 1). The marked absence of
histopathology two weeks after the induction of immunologic
injury in these animals brings into focus the potent anti-
inflammatory action of this dietary intervention. The mecha-
nisms underlying this effect of EFAD on renal and nonrenal
forms of immunologic injury have been addressed in previous
studies [5—8]. As has been documented [8], the number of
resident glomerular macrophages is diminished in EFAD ani-
mals and the influx of macrophages into a focus of glomerular
inflammation is markedly attenuated, as is glomerular ei-
cosanoid synthesis. These effects on macrophage function are
clearly central to the physiological protection conferred by
EFAD. The mechanism by which EFAD interferes with mac-
rophage elicitation remains to be clarified. Evidence from
previous studies excludes depletion of circulating monocytes or
impairment of macrophage chemotactic responsiveness [5—8].
Recently, a novel arachidonate-linked lipid monocyte chemo-
tactic factor has been identified from glomeruli of NTS nephritic
rats [8]. Its structure is as yet uncharacterized.
Effects on proteinuria
Upr increased dramatically in STD animals three hours after
receiving NTS. In EFAD nephritic animals, U was only
slightly, but significantly, diminished as compared to STD
nephritic rats. However, in contrast to glomerular hemody-
namic changes, Upr remained markedly increased as compared
to STD non-nephritic animals. Neutrophil activation leads to
enzymatic-induced damage to the glomerular capillary wall
[24], which may play a role in mediating the proteinuria
accompanying the early phase of nephrotoxic nephritis. Mor-
ganroth et al [25] reported that neutrophils obtained from
LEAD rats exhibited slightly decreased superoxide production,
and similar rates for release of degradative enzymes as com-
pared to those observed in STD rats. As we have previously
reported, despite depleting glomerular leukocytes under basal
conditions, the EFAD status does not diminish the degree of
neutrophil infiltration characteristic of this phase of the lesion
[5], suggesting that neutrophils damage the basement mem-
brane via mechanisms independent of arachidonate. Perpetua-
tion of neutrophil-initiated capillary wall damage and persis-
tence of proteinuria into the chronic phase, however, appears to
require the activation of lipid-mediator dependent responses.
This is evidenced by the marked attenuation of proteinuria in
this disease at two weeks by cyclooxygenase inhibition [9], and
its complete absence at that time point in EFAD animals in the
present study (Fig. 3).
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In summary, the present study provides evidence that EFAD
confers complete protection against the histopathologic as well
as the functional sequelae of immune-initiated injury in the
glomerulus. The data suggest that the mere deposition of
antibody, and the initial wave of complement-induced neutro-
phil infiltration, with its attendant proteinuria, are not sufficient
to perpetuate injury into the more destructive chronic phases.
The central lipid abnormality in EFAD is the lack of availability
of arachidonic acid. Since the enzymatic and non-enzymatic
products of arachidonate metabolism have been implicated in
the pathogenesis of the histologic and the functional sequelae of
glomerulonephritis, the present studies provide strong impetus
for the design of more specific interventional therapies, target-
ting the various enzymes and products of these pathways, in the
attempts to control glomerular inflammation.
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